Press Releases on November 3, 2015 - EIN Presswire - Press Release Distribution Service

Published on November 3, 2015 - 12:12 GMT

West Coast, Rocky Mountains Regions Lead U.S. in Renewable Energy Project Development, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 11/03/15 -- Researched by Industrial Info Resources (Sugar Land, Texas) -- Industrial Info is tracking more than 1,800 renewable energy projects in the Power Generation Industry that are currently under way or are set to …

Distribution channels: Consumer Goods, Energy Industry ...

Published on November 3, 2015 - 12:08 GMT

GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment

LONDON & KENILWORTH, N.J.--(BUSINESS WIRE)--GSK and Merck, known as MSD outside the US and Canada, today announced the initiation of a phase I clinical trial designed to evaluate GSK’s investigational immunotherapy GSK3174998 as monotherapy and in …

Distribution channels: Companies

Published on November 3, 2015 - 12:06 GMT

Manhattan Institute hires John Tierney as contributing editor to City Journal

NEW YORK, Nov. 3, 2015 (GLOBE NEWSWIRE) -- The Manhattan Institute is pleased to welcome best-selling author and columnist John Tierney as contributing editor to its quarterly publication, City Journal. Tierney brings with him significant experience in …

Distribution channels: Culture, Society & Lifestyle, Politics

Published on November 3, 2015 - 12:05 GMT

Endonovo Therapeutics Developing Next-Generation Cell Therapy for Acute and Chronic Graft-Versus-Host Disease Using Cell-Enhancing ...

Cytotronics™ Platform Allows for the Large-Scale Expansion and Enhancement of Immuno-Regulatory Stem Cells With Enhanced Biological and Therapeutic Properties LOS ANGELES, CA - (NewMediaWire) - November 03, 2015 - Endonovo Therapeutics, Inc. (OTCQB: ENDV …

Distribution channels: World & Regional

Published on November 3, 2015 - 12:05 GMT

GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment

LONDON & KENILWORTH, N.J.--(BUSINESS WIRE)--GSK and Merck, known as MSD outside the US and Canada, today announced the initiation of a phase I clinical trial designed to evaluate GSK’s investigational immunotherapy GSK3174998 as monotherapy and in …

Distribution channels: Companies

Published on November 3, 2015 - 12:05 GMT

Intercept Announces Data to be Presented at the 2015 AASLD Annual Meeting

NEW YORK, Nov. 3, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic, underserved liver diseases, today …

Distribution channels: Conferences & Trade Fairs, Technology

Published on November 3, 2015 - 12:05 GMT

Targa Resources Corp. Announces Agreement to Acquire Targa Resources Partners LP

Immediately accretive to TRC shareholders TRP unitholders to receive 0.62 shares of TRC per unit in all equity transaction 18% premium to TRP 10-trading day volume weighted average closing price 15% 2016 estimated dividend growth Greater than 10% estimated …

Distribution channels: Banking, Finance & Investment Industry